U.S. Congress Seeks to Expand CBD and Medical Marijuana Research

Share the love
On June 27, 2019, Senators Dianne Feinstein (D-Calif.), Chuck Grassley (R-Iowa), and Brian Schatz (D-Hawaii) co-sponsored the Cannabidiol and Marijuana Research Expansion Act. Backed by the American Medical Association (AMA), this bipartisan bill helps bolster scientific research into marijuana and cannabidiol (CBD), one of active compounds in the cannabis plant. Some of the key provisions include: Reducing barriers to federally authorized marijuana research; Streamlining the development of FDA-approved medications derived CBD and marijuana; Allowing doctors to discuss the benefits of marijuana treatments for children and adults; Requiring the Department of Health and Human Services (HHS) to report to Congress about the effects of marijuana and provide recommendations to help facilitate medical research on marijuana and its components. Read full story by Michael Best & Friedrich LLP here.

Leave a Reply